Showing results (621-630 of 701) with videos related to

Sort By:
Pageof 71
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 6, 2026
Vitamin K status and vascular health in a general populationJulie Aaberg Lauridsen, Camilla Friis Bryde Nielsen, Line Lund Kårhus, et al.
Clinical Pharmacology and Therapeutics|July 27, 2022
Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney DiseaseJ David Smeijer, Jeroen V Koomen, Donald E Kohan, et al.
Lancet (London, England)|September 28, 2012
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysisCaroline S Fox, Kunihiro Matsushita, Mark Woodward, et al.
Diabetes Research and Clinical Practice|October 7, 2023
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trialHiddo J L Heerspink, Andreas L Birkenfeld, David Z I Cherney, et al.
Cardiovascular Diabetology|August 31, 2025
Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular diseaseAdam Chebli, Ida K B Rasmussen, Anne-Cathrine Skriver-Møller, et al.
Diabetes Care|July 10, 2021
Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 DiabetesFarsad Afshinnia, Thekkelnaycke M Rajendiran, Chenchen He, et al.
Kidney International Reports|May 2, 2022
Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic RegionsPriya Vart, Ricardo Correa-Rotter, Fan Fan Hou, et al.
Cardiovascular Diabetology|April 18, 2025
Sex differences in myocardial flow reserve among individuals with type 2 diabetes: insights from the DiaHeart studyAnne-Cathrine Skriver-Møller, Philip Hasbak, Ida K B Rasmussen, et al.
Diabetologia|December 6, 2014
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetesMarine Germain, Marcus G Pezzolesi, Niina Sandholm, et al.
Diabetes Research and Clinical Practice|October 20, 2022
Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL studyViktor Rotbain Curovic, Neil Roy, Tine W Hansen, et al.
Pageof 71